CN104815339A - Diagnostic product for crux of refractory diseases - Google Patents

Diagnostic product for crux of refractory diseases Download PDF

Info

Publication number
CN104815339A
CN104815339A CN201510224756.9A CN201510224756A CN104815339A CN 104815339 A CN104815339 A CN 104815339A CN 201510224756 A CN201510224756 A CN 201510224756A CN 104815339 A CN104815339 A CN 104815339A
Authority
CN
China
Prior art keywords
crux
diagnostic product
tonifying
purely
difficult treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510224756.9A
Other languages
Chinese (zh)
Inventor
孙宏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510224756.9A priority Critical patent/CN104815339A/en
Publication of CN104815339A publication Critical patent/CN104815339A/en
Pending legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention provides a diagnostic product used for acquiring information of a crux of refractory diseases, wherein the diagnostic product also is a functional food for greatly and purely tonifying qi blood and yin-yang. The diagnostic product also is suitable for detecting the crux of cancer and purely tonifying vitality. The diagnostic product includes 9% of ginseng, 58% of radix rehmanniae preparata, 9% of cinnamon, 6% of dry ginger, 9% of radix glycyrrhizae and 9% of cordyceps sinensis. The diagnostic product can be prepared into following preparations: powder, pills, tablets, electuaries, liquors, capsules, syrups and the like. In the invention, by means of a characteristic that the functional food for greatly and purely tonifying qi blood and yin-yang acts in body to generate reactions, the information of the crux of refractory diseases can be obtained in-vitro.

Description

Difficult treatment crux diagnosis product
Technical field the present invention is a kind of diagnostic article for obtaining difficult treatment crux information, relates to the functional food for mending greatly the pure negative and positive that fill blood simultaneously.
The diagnostic article that can be used for difficult treatment crux and check is not produced and sold to background technology up to now, at home and abroad, also do not find not only can be used for the diagnosis of difficult treatment crux but also can be used for mending greatly the functional food of pure invigorating primordial QI of patent statement.
Summary of the invention the object of this invention is to provide a kind of diagnostic article of the difficult treatment of acquisition in vitro crux information and the large functional food mending the pure negative and positive that fill blood.Batching of the present invention comprises: Radix Ginseng 9%, Radix Rehmanniae Preparata 58%, Cortex Cinnamomi 9%, Rhizoma Zingiberis 6%, Radix Glycyrrhizae 9%, Cordyceps 9%.The present invention is the reaction characteristics utilizing the large functional food mending the pure negative and positive that fill blood to act in vivo and produce, and obtains the information of difficult treatment crux in vitro.
Detailed description of the invention powder of the present invention adds man-hour, whole raw material is shone dry grinding and grinds into powder, mix homogeneously.Raw material of the present invention also can be used to manufacture the multiple dosage forms such as pill, tablet, electuary, medicated wine, capsule and syrup.

Claims (3)

1. for obtaining a diagnostic article for difficult treatment crux information, it is characterized in that: batching comprises: Radix Ginseng 9%, Radix Rehmanniae Preparata 58%, Cortex Cinnamomi 9%, Rhizoma Zingiberis 6%, Radix Glycyrrhizae 9%, Cordyceps 9%.
2. the diagnostic article for obtaining difficult treatment crux information according to claim 1, is characterized in that: raw material can be used to the multiple dosage forms such as processing powder, pill, tablet, electuary, medicated wine, capsule and syrup.
3. the diagnostic article for obtaining difficult treatment crux information according to claim 2, is characterized in that: various preparation all can be used for the pure benefit of large benefit of negative and positive of qi and blood.
CN201510224756.9A 2015-04-28 2015-04-28 Diagnostic product for crux of refractory diseases Pending CN104815339A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510224756.9A CN104815339A (en) 2015-04-28 2015-04-28 Diagnostic product for crux of refractory diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510224756.9A CN104815339A (en) 2015-04-28 2015-04-28 Diagnostic product for crux of refractory diseases

Publications (1)

Publication Number Publication Date
CN104815339A true CN104815339A (en) 2015-08-05

Family

ID=53725971

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510224756.9A Pending CN104815339A (en) 2015-04-28 2015-04-28 Diagnostic product for crux of refractory diseases

Country Status (1)

Country Link
CN (1) CN104815339A (en)

Similar Documents

Publication Publication Date Title
CN102302684A (en) Radix notoginseng tablets for promoting blood circulation
CN112972547A (en) Traditional Chinese medicine composition for treating qi-blood deficiency syndrome and preparation method and application thereof
CN103768123A (en) Traditional Chinese medicine composition and preparation method thereof
CN103251856B (en) Traditional Chinese medicine preparation for benefiting Qi and nourishing blood and preparation method of traditional Chinese medicine preparation
CN104815339A (en) Diagnostic product for crux of refractory diseases
CN102716436A (en) Capsule for treating atrophic gastritis
CN102846765B (en) Hawthorn vitamin C tablets and production method thereof
CN102150841A (en) Instant herbal health-care medicament with function of enhancing immunity and preparation method thereof
CN102716438A (en) Pill for treating atrophic gastritis
CN104013684A (en) Pelvic inflammation treating tablet and preparation method thereof
CN104547976A (en) Traditional Chinese medicinal composition for treating esophagus cancer
CN102836315A (en) Chinese medicinal composition for preventing and conditioning prognosis tumors and preparation method thereof
CN102847041A (en) A Chinese medicinal formulation for treating puerperal depression
CN101606963B (en) Traditional Chinese medicine combination for enhancing disintoxication and improving dyscrasia of cancer patients
CN103202918A (en) Chinese patent drug for treating azoospermatism
CN103585355A (en) Cortex Lycii pill
CN105902748A (en) Medicine for curing human cancer and production method thereof
CN103300370A (en) Cordyceps sinensis astragalus membranaceus capsule
CN108686054A (en) Anti-aging medicament and preparation method
CN102973712A (en) Traditional Chinese medicine composition for treating knee joint rheumatalgia
CN108853273A (en) Anti-aging medicament and preparation method
CN102670990A (en) Method for preparing dendrobium nobile crystal
CN103877529A (en) Formula and production process for medicinal liquor used for treating rheumatism
CN103300353A (en) Ganoderma lucidum soft capsule
CN103816473A (en) Traditional Chinese medicine for treating febrile diseases and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150805